Manchester Financial Inc Sorrento Therapeutics, Inc. Transaction History

Manchester Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$6.35 - $10.0 $13,176 - $20,750	-2,075 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$7.03 - $16.51 $527 - $1,238	75 Added 3.75%	2,075 $17,000
Q4 2020 Jan 26, 2021	SELL	$5.76 - $11.95 $17,602 - $36,519	-3,056 Reduced 60.44%	2,000 $14,000
Q3 2020 Oct 15, 2020	SELL	$6.17 - $18.82 $30,504 - $93,046	-4,944 Reduced 49.44%	5,056 $56,000
Q2 2020 Jul 13, 2020	BUY	$1.73 - $6.76 $17,300 - $67,600	10,000 New	10,000 $63,000

5.48M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.